|
|
|
|
|
|
Sierra Oncology Inc (SRRA)
|
|
1.51 +0.01 (+0.67%)
|
8/23/2017 2:59pm
|
|
Open:
|
1.49
|
Pre. Close:
|
1.50
|
|
High:
|
1.54
|
Low:
|
1.48
|
|
Volume:
|
72,590
|
Market Cap:
|
78.92M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
-
|
-
|
|
Low:
|
-
|
-
|
|
Close:
|
-
|
-
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-23 2:40:49 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 1.85 One year: 2.16
|
|
Support:
|
Support1: 1.43 Support2: 1.33
|
|
Resistance:
|
Resistance1:
1.58 Resistance2: 1.85
|
|
Pivot:
|
1.52
|
|
Moving Averages:
|
MA(5): 1.51  MA(20): 1.51
MA(100): 1.32 MA(250): 1.47
|
|
MACD:
|
MACD(12,26):
0.05 Signal(12,26,9): 0.06
|
|
%K %D:
|
%K(14,3): 64.81 %D(3): 67.11
|
|
RSI:
|
RSI(14): 57.18
|
|
52-Week:
|
High: 2.07
Low: 1.10 Change(%): -20.5
|
|
Average Vol(K):
|
3-Month: 30700
10-Days 9020
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.SRRA has closed above bottom band by 40.3%. Bollinger Bands are 48.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to SRRA's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Mon, 17 Jul 2017 17:37:30 GMT
Revisiting The ProNAi/Sierra Oncology Thesis 1 Year Later: Still Not Dead In ...
Mon, 09 Jan 2017 12:00:00 GMT
ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs
Mon, 05 Jun 2017 11:44:12 GMT
Sierra Oncology shares jump 7.3% premarket on news of positive early-stage ...
Tue, 22 Aug 2017 20:03:45 GMT
Active Stocks on Watch: Dolby Laboratories Inc (DLB) and Sierra Oncology Inc ...
Wed, 23 Aug 2017 16:52:30 GMT
How Technical Indicators Have Come Out? – Prospect Capital Corporation (PSEC ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
